Physical–Chemical Approach to Designing Drugs with Multiple Targets
Source abstract
Abstract
Many people simultaneously exhibit multiple diseases, which complicates efficient medical treatments. For example, patients with cancer are frequently susceptible to infections. However, developing drugs that could simultaneously target several diseases is challenging. We present a novel theoretical method to assist in selecting compounds with multiple therapeutic targets. The idea is to find correlations between the physical and chemical properties of drug molecules and their abilities to work against multiple targets. As a first step, we investigated potential drugs against cancer and viral infections. Specifically, we investigated antimicrobial peptides (AMPs), which are short positively charged biomolecules produced by living systems as a part of their immune defense. AMPs show anticancer and antiviral activity. We use chemoinformatics and correlation analysis as a part of the machine-learning method to identify the specific properties that distinguish AMPs with dual anticancer and antiviral activities. Physical-chemical arguments to explain these observations are presented.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · Chemical Synthesis and Analysis · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Rice University, Houston, Texas 77005, United States
Center for Theoretical Biological Physics, Rice University, Houston, Texas 77005, United States
Department of Chemical and Biomolecular Engineering, Rice University, Houston, Texas 77005, United States
Department of Physics and Astronomy, Rice University, Houston, Texas 77005, United States
Funding
Division of Chemistry · Welch Foundation · Division of Physics
References (69)
Show source-provided references
1. Boersma, P.; Black, L. I.; Ward, B. W. Prevalence of Multiple Chronic Conditions Among US Adults, 2018. 2020.10.5888/pcd17.200130 ↗
2. Hota, D.; Tripathy, A. Cancer Diagnostics and Therapeutics: Current Trends, Challenges, and Future Perspectives; Springer, 2022; pp 287–302.10.1007/978-981-16-4752-9_13 ↗
3. 10.1158/2159-8290.CD-19-076110.1158/2159-8290.CD-19-0761 ↗
4. 10.1038/s41591-020-0892-610.1038/s41591-020-0892-6 ↗
5. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
6. 10.3390/cancers1407167110.3390/cancers14071671 ↗
7. 10.25259/SNI_351_201910.25259/SNI_351_2019 ↗
8. 10.1016/j.semcancer.2014.01.00410.1016/j.semcancer.2014.01.004 ↗
9. 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-010.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0 ↗
10. 10.1200/JCO.2019.37.15_suppl.e2309510.1200/JCO.2019.37.15_suppl.e23095 ↗
11. 10.1038/nrd70310.1038/nrd703 ↗
12. 10.1038/s41579-021-00530-x10.1038/s41579-021-00530-x ↗
13. 10.1016/S0074-7696(05)45006-810.1016/S0074-7696(05)45006-8 ↗
14. 10.1126/sciadv.adg343310.1126/sciadv.adg3433 ↗
15. 10.1038/nri209810.1038/nri2098 ↗
16. 10.1016/B978-0-323-04404-2.10027-210.1016/B978-0-323-04404-2.10027-2 ↗
17. 10.1097/00001432-200208000-0000210.1097/00001432-200208000-00002 ↗
18. 10.1007/s00109-006-0143-410.1007/s00109-006-0143-4 ↗
19. 10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M10.1002/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M ↗
20. 10.15212/bioi-2020-001310.15212/bioi-2020-0013 ↗
21. 10.1186/s40779-021-00343-210.1186/s40779-021-00343-2 ↗
22. 10.1111/jfbc.1254610.1111/jfbc.12546 ↗
23. 10.1042/BST2020085410.1042/BST20200854 ↗
24. 10.1007/s10555-020-09872-z10.1007/s10555-020-09872-z ↗
25. 10.1016/j.jconrel.2015.10.04010.1016/j.jconrel.2015.10.040 ↗
26. 10.1016/j.cbi.2022.11019410.1016/j.cbi.2022.110194 ↗
27. 10.1186/s12935-022-02553-710.1186/s12935-022-02553-7 ↗
28. 10.1039/D0RA09898A10.1039/D0RA09898A ↗
29. 10.17179/excli2018-144710.17179/excli2018-1447 ↗
30. 10.3389/fonc.2022.81956310.3389/fonc.2022.819563 ↗
31. 10.1007/s00018-019-03138-w10.1007/s00018-019-03138-w ↗
32. 10.3390/ijms2405432810.3390/ijms24054328 ↗
33. 10.1002/cmdc.20180020410.1002/cmdc.201800204 ↗
34. 10.3390/molecules2803114810.3390/molecules28031148 ↗
35. 10.3389/fgene.2020.0076010.3389/fgene.2020.00760 ↗
36. Adari, G. K.; Raja, M.; Vijaya, P. Data Science for Genomics; Elsevier, 2023; pp 25–68.10.1016/B978-0-323-98352-5.00007-0 ↗
37. 10.3390/ijms2008196410.3390/ijms20081964 ↗
38. 10.1111/cbdd.1303110.1111/cbdd.13031 ↗
39. 10.1186/s12934-022-01848-810.1186/s12934-022-01848-8 ↗
40. 10.1093/nar/gkv127810.1093/nar/gkv1278 ↗
41. 10.1093/bioinformatics/btt07210.1093/bioinformatics/btt072 ↗
42. 10.1021/acs.jcim.2c0155110.1021/acs.jcim.2c01551 ↗
43. 10.18632/oncotarget.2036510.18632/oncotarget.20365 ↗
44. 10.18632/oncotarget.781510.18632/oncotarget.7815 ↗
45. 10.1093/bib/bbaa15310.1093/bib/bbaa153 ↗
46. 10.1371/journal.pone.007016610.1371/journal.pone.0070166 ↗
47. 10.1016/j.jcis.2021.08.20010.1016/j.jcis.2021.08.200 ↗
48. 10.1093/oxfordjournals.molbev.a00398810.1093/oxfordjournals.molbev.a003988 ↗
49. 10.1093/oxfordjournals.molbev.a02634410.1093/oxfordjournals.molbev.a026344 ↗
50. 10.1093/protein/gzw02310.1093/protein/gzw023 ↗
51. 10.1371/journal.pone.018090510.1371/journal.pone.0180905 ↗
52. 10.3390/ijms2022574310.3390/ijms20225743 ↗
53. 10.1007/s00232-023-00286-w10.1007/s00232-023-00286-w ↗
54. 10.3389/fimmu.2022.91036710.3389/fimmu.2022.910367 ↗
55. Brandt G. S. · 2018
56. 10.1039/D0FD00041H10.1039/D0FD00041H ↗
57. 10.3390/molecules1807740710.3390/molecules18077407 ↗
58. 10.3390/ijms14091875810.3390/ijms140918758 ↗
59. 10.1016/j.bpj.2018.05.00610.1016/j.bpj.2018.05.006 ↗
60. 10.1007/s00249-009-0567-110.1007/s00249-009-0567-1 ↗
61. 10.3390/separations1002008110.3390/separations10020081 ↗
62. 10.1186/s12985-019-1182-010.1186/s12985-019-1182-0 ↗
63. 10.1093/nar/gks45010.1093/nar/gks450 ↗
64. 10.1007/s00018-019-03138-w10.1007/s00018-019-03138-w ↗
65. 10.1007/s00232-022-00233-110.1007/s00232-022-00233-1 ↗
66. 10.1007/s00232-022-00267-510.1007/s00232-022-00267-5 ↗
67. 10.1093/nar/gkz85010.1093/nar/gkz850 ↗
68. 10.1186/s11658-022-00332-w10.1186/s11658-022-00332-w ↗
69. 10.1093/nar/gky73510.1093/nar/gky735 ↗